Joseph Driscoll is Chief Financial Officer of Akoya Biosciences, Inc.. Currently has a direct ownership of 262,500 shares of AKYA, which is worth approximately $716,625. The most recent transaction as insider was on Dec 22, 2022, when has been sold 250,000 shares (Common Stock) at a price of $0.44 per share, resulting in proceeds of $110,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K
0% 3M change
0% 12M change
Total Value Held $716,625

JOSEPH DRISCOLL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2022
BUY
Exercise of conversion of derivative security
$110,000 $0.44 p/Share
250,000 Added 48.78%
262,500 Common Stock
Dec 14 2022
SELL
Open market or private sale
$309,385 $12.57 p/Share
24,613 Reduced 66.32%
12,500 Common Stock
Dec 14 2022
BUY
Exercise of conversion of derivative security
$10,829 $0.44 p/Share
24,613 Added 47.62%
27,074 Common Stock
Mar 23 2022
BUY
Grant, award, or other acquisition
-
12,500 Added 50.0%
12,500 Common Stock
JD

Joseph Driscoll

Chief Financial Officer
Marlborough, MA

Track Institutional and Insider Activities on AKYA

Follow Akoya Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKYA shares.

Notify only if

Insider Trading

Get notified when an Akoya Biosciences, Inc. insider buys or sells AKYA shares.

Notify only if

News

Receive news related to Akoya Biosciences, Inc.

Track Activities on AKYA